Real-World Data & Analytics

Health Advances helped an oncology-focused clinical trial software and services company develop its growth strategy for biopharma concentrating on RWD and eClinical software. Our team assessed the current use of such technologies within biopharma, estimated spend patterns and addressable market sizes, along with unmet needs in the context of the competitive landscape. We prioritized opportunities within RWD data and eClinical software for biopharmaceuticals in clinical development, presenting our client to with several strategic options for near-term growth and potential longer-term implications.

Health Advances helped a multi-state health system develop a monetization strategy for their oncology data assets, including EHR, claims, NGS testing, pathology images, PROs, and health economics data. Seeking to capitalize on growing demand among biopharma companies for direct access to real world data (RWD), particularly in oncology, the provider sought a data-driven perspective on the size and nature of the monetization opportunity. The team's analysis included an in-depth analysis of biopharma use cases and activity in the use of oncology RWD, as well as an extensive competitive landscape assessment to identify potential differentiators and opportunities for the client based on their unique data assets. With a clear roadmap of near-term and long-term opportunities, the size and price points for those opportunities, and the investments required to unlock those opportunities, the health system was able to move forward with confidence. 

Health Advances supported a company offering a leading analytics platform for real world data to refine its growth strategy and better understand its competitive positioning in selling its platform to biopharma companies.  Health Advances took a two-pronged approach to answer this question. The team first completed a comprehensive primary research program with stakeholders from a number of different functional areas within biopharma companies to understand the use cases and needs of each different functional area. By assessing the key strengths, weaknesses, and capabilities of the client and other competing platforms and overlaying these findings on the findings from the primary research, Health Advances was able to identify several priority segments where the client's platform offered clear differentiation from competing platforms. Based on the team's findings, the client began to develop a more marketing and sales strategy that was more targeted and refined than the ad hoc tactics it had employed in the past. 

An emerging real-world data (RWD) analytics company engaged Health Advances to deliver a growth strategy that expands into other therapeutic areas. Working against a short timeline, the team created an initial framework for prioritization based on therapeutic area market size, demand for data analytics among potential customers, and maturity of existing data sources. A rapid prioritization against this framework quickly identified the top five therapeutic areas for further deep-dives. The team modeled the total addressable market for each opportunity across several RWD use cases in clinical development, health economics and outcomes research, medical affairs, and commercialization. We prioritized each opportunity against a more detailed seven-point framework and synthesized findings into recommendations for a near-term and long-term growth strategy. The client used the insights and recommendations to raise additional funding and expand into additional therapeutic areas.